SANA
Price:
$5.04
Market Cap:
$1.12B
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia;...[Read more]
Industry
Biotechnology
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
SANA
According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.08B. This represents a change of -10.46% compared to the average of 1.21B of the last 4 quarters.
The mean historical Enterprise Value of Sana Biotechnology, Inc. over the last ten years is 3.87B. The current 1.08B Enterprise Value has changed 2.70% with respect to the historical average. Over the past ten years (40 quarters), SANA's Enterprise Value was at its highest in in the December 2020 quarter at 5.81B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
3.87B
Median
4.34B
Minimum
675.45M
Maximum
6.54B
Discovering the peaks and valleys of Sana Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.59%
Maximum Annual Enterprise Value = 6.54B
Minimum Annual Increase = -72.25%
Minimum Annual Enterprise Value = 675.45M
Year | Enterprise Value | Change |
---|---|---|
2023 | 760.47M | 12.59% |
2022 | 675.45M | -72.25% |
2021 | 2.43B | -61.00% |
2020 | 6.24B | -4.62% |
2019 | 6.54B | -0.02% |
The current Enterprise Value of Sana Biotechnology, Inc. (SANA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.29B
5-year avg
3.33B
10-year avg
3.87B
Sana Biotechnology, Inc.’s Enterprise Value is greater than Olema Pharmaceuticals, Inc. (662.53M), greater than Cullinan Oncology, Inc. (930.13M), greater than aTyr Pharma, Inc. (138.44M), greater than Zentalis Pharmaceuticals, Inc. (217.53M), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Galera Therapeutics, Inc. (-5475585.00), greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Day One Biopharmaceuticals, Inc. (1.01B), greater than HOOKIPA Pharma Inc. (87.25M), less than Revolution Medicines, Inc. (6.80B), less than Blueprint Medicines Corporation (6.16B), less than Kymera Therapeutics, Inc. (2.92B), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Nkarta, Inc. (340.55M), greater than Lyell Immunopharma, Inc. (226.32M), greater than Generation Bio Co. (210.95M), less than Mirati Therapeutics, Inc. (3.91B), greater than Amylyx Pharmaceuticals, Inc. (89.50M), less than Apellis Pharmaceuticals, Inc. (5.11B),
Company | Enterprise Value | Market cap |
---|---|---|
662.53M | $677.46M | |
930.13M | $1.04B | |
138.44M | $131.12M | |
217.53M | $210.48M | |
40.79M | $109.78M | |
-5475585.00 | $4.08M | |
458.36M | $549.60M | |
1.01B | $1.25B | |
87.25M | $159.50M | |
6.80B | $6.99B | |
6.16B | $5.47B | |
2.92B | $2.89B | |
284.72M | $349.21M | |
340.55M | $375.37M | |
226.32M | $299.52M | |
210.95M | $145.50M | |
3.91B | $4.12B | |
89.50M | $161.36M | |
5.11B | $5.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sana Biotechnology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sana Biotechnology, Inc. (SANA)?
What is the 3-year average Enterprise Value for Sana Biotechnology, Inc. (SANA)?
What is the 5-year average Enterprise Value for Sana Biotechnology, Inc. (SANA)?
How does the current Enterprise Value for Sana Biotechnology, Inc. (SANA) compare to its historical average?